151 related articles for article (PubMed ID: 28356756)
1. Suppression of microRNA-629 enhances sensitivity of cervical cancer cells to 1'S-1'-acetoxychavicol acetate via regulating RSU1.
Phuah NH; Azmi MN; Awang K; Nagoor NH
Onco Targets Ther; 2017; 10():1695-1705. PubMed ID: 28356756
[TBL] [Abstract][Full Text] [Related]
2. Down-Regulation of MicroRNA-210 Confers Sensitivity towards 1'S-1'-Acetoxychavicol Acetate (ACA) in Cervical Cancer Cells by Targeting SMAD4.
Phuah NH; Azmi MN; Awang K; Nagoor NH
Mol Cells; 2017 Apr; 40(4):291-298. PubMed ID: 28401751
[TBL] [Abstract][Full Text] [Related]
3. Novel purification of 1'S-1'-Acetoxychavicol acetate from Alpinia galanga and its cytotoxic plus antiproliferative activity in colorectal adenocarcinoma cell line SW480.
Baradwaj RG; Rao MV; Senthil Kumar T
Biomed Pharmacother; 2017 Jul; 91():485-493. PubMed ID: 28477464
[TBL] [Abstract][Full Text] [Related]
4. Alterations of microRNA expression patterns in human cervical carcinoma cells (Ca Ski) toward 1'S-1'-acetoxychavicol acetate and cisplatin.
Phuah NH; In LL; Azmi MN; Ibrahim H; Awang K; Nagoor NH
Reprod Sci; 2013 May; 20(5):567-78. PubMed ID: 23012319
[TBL] [Abstract][Full Text] [Related]
5. The apoptotic effect of 1'S-1'-Acetoxychavicol Acetate (ACA) enhanced by inhibition of non-canonical autophagy in human non-small cell lung cancer cells.
Sok SP; Arshad NM; Azmi MN; Awang K; Ozpolat B; Hasima Nagoor N
PLoS One; 2017; 12(2):e0171329. PubMed ID: 28158287
[TBL] [Abstract][Full Text] [Related]
6. Anti-proliferative, apoptotic induction, and anti-migration effects of hemi-synthetic 1'
Liew SK; Azmi MN; In L; Awang K; Nagoor NH
Drug Des Devel Ther; 2017; 11():2763-2776. PubMed ID: 29075101
[TBL] [Abstract][Full Text] [Related]
7. The apoptotic effect of 1's-1'-acetoxychavicol acetate from Alpinia conchigera on human cancer cells.
Awang K; Azmi MN; Aun LI; Aziz AN; Ibrahim H; Nagoor NH
Molecules; 2010 Nov; 15(11):8048-59. PubMed ID: 21063268
[TBL] [Abstract][Full Text] [Related]
8. MiR-519d represses ovarian cancer cell proliferation and enhances cisplatin-mediated cytotoxicity in vitro by targeting XIAP.
Pang Y; Mao H; Shen L; Zhao Z; Liu R; Liu P
Onco Targets Ther; 2014; 7():587-97. PubMed ID: 24790458
[TBL] [Abstract][Full Text] [Related]
9. Long Noncoding RNA GAS5, Which Acts as a Tumor Suppressor via microRNA 21, Regulates Cisplatin Resistance Expression in Cervical Cancer.
Wen Q; Liu Y; Lyu H; Xu X; Wu Q; Liu N; Yin Q; Li J; Sheng X
Int J Gynecol Cancer; 2017 Jul; 27(6):1096-1108. PubMed ID: 28472815
[TBL] [Abstract][Full Text] [Related]
10. 1'S-1'-acetoxyeugenol acetate: a new chemotherapeutic natural compound against MCF-7 human breast cancer cells.
Hasima N; Aun LI; Azmi MN; Aziz AN; Thirthagiri E; Ibrahim H; Awang K
Phytomedicine; 2010 Oct; 17(12):935-9. PubMed ID: 20729047
[TBL] [Abstract][Full Text] [Related]
11. [miR-143 inhibits cell proliferation through targeted regulating the expression of K-ras gene in HeLa cells].
Qin HX; Cui HK; Pan Y; Hu RL; Zhu LH; Wang SJ
Zhonghua Zhong Liu Za Zhi; 2016 Dec; 38(12):893-897. PubMed ID: 27998464
[No Abstract] [Full Text] [Related]
12. miR-202 Enhances the Anti-Tumor Effect of Cisplatin on Non-Small Cell Lung Cancer by Targeting the Ras/MAPK Pathway.
Sun W; Ping W; Tian Y; Zou W; Liu J; Zu Y
Cell Physiol Biochem; 2018; 51(5):2160-2171. PubMed ID: 30522099
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-493-5p promotes apoptosis and suppresses proliferation and invasion in liver cancer cells by targeting VAMP2.
Wang G; Fang X; Han M; Wang X; Huang Q
Int J Mol Med; 2018 Mar; 41(3):1740-1748. PubMed ID: 29328362
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-331-3p Suppresses Cervical Cancer Cell Proliferation and E6/E7 Expression by Targeting NRP2.
Fujii T; Shimada K; Asano A; Tatsumi Y; Yamaguchi N; Yamazaki M; Konishi N
Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27548144
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-409-5p is upregulated in breast cancer and its downregulation inhibits cancer development through downstream target of RSU1.
Yu H; Xing H; Han W; Wang Y; Qi T; Song C; Xu Z; Li H; Huang Y
Tumour Biol; 2017 May; 39(5):1010428317701647. PubMed ID: 28459205
[TBL] [Abstract][Full Text] [Related]
16. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP.
Zhu W; Xu H; Zhu D; Zhi H; Wang T; Wang J; Jiang B; Shu Y; Liu P
Cancer Chemother Pharmacol; 2012 Mar; 69(3):723-31. PubMed ID: 21993663
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-195 inhibits the behavior of cervical cancer tumors by directly targeting HDGF.
Song R; Cong L; Ni G; Chen M; Sun H; Sun Y; Chen M
Oncol Lett; 2017 Jul; 14(1):767-775. PubMed ID: 28693232
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-708 Suppresses Cell Proliferation and Enhances Chemosensitivity of Cervical Cancer Cells to cDDP by Negatively Targeting Timeless.
Zou X; Zhu C; Zhang L; Zhang Y; Fu F; Chen Y; Zhou J
Onco Targets Ther; 2020; 13():225-235. PubMed ID: 32021269
[TBL] [Abstract][Full Text] [Related]
19. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC.
Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W
Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155
[No Abstract] [Full Text] [Related]
20. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
